Core Laboratories (CLB) Revenue (2022 - 2026)

Core Laboratories' Revenue history runs 5 years deep, the most recent figure standing at $121.8 million for Q1 2026.

• On a quarterly basis, Revenue fell 1.45% year-over-year to $121.8 million in Q1 2026; TTM through Mar 2026 was $524.7 million, a 1.34% increase from a year earlier, with the FY2025 full-year figure at $526.5 million, up 0.51% from the prior year.
• Revenue eased to $121.8 million in Q1 2026 per CLB's latest filing, from $138.3 million in the prior quarter.
• Across five years, Revenue topped out at $138.3 million in Q4 2025 and bottomed at $120.9 million in Q2 2022.
• The 5-year median for Revenue is $128.3 million (2023), against an average of $128.5 million.
• Across the five-year window, Revenue climbed 7.22% in 2024 and decreased 4.67% in 2025, its largest moves.
• Year by year, Revenue stood at $127.6 million in 2022, then gained by 0.5% to $128.2 million in 2023, then climbed by 0.8% to $129.2 million in 2024, then rose by 6.98% to $138.3 million in 2025, then retreated by 11.9% to $121.8 million in 2026.
• Per Business Quant, the three latest CLB Revenue figures stand at $121.8 million (Q1 2026), $138.3 million (Q4 2025), and $134.5 million (Q3 2025).